Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,707 | -5,068 | -1,967 | -47,221 | -38,719 |
| Depreciation Amortization | 58 | 8 | 5 | 591 | 586 |
| Other Working Capital | -1,154 | 4 | -233 | -522 | -203 |
| Other Operating Activity | 2,834 | 1,184 | 523 | 42,343 | 34,837 |
| Operating Cash Flow | $-5,968 | $-3,873 | $-1,671 | $-4,809 | $-3,499 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -8 | -2 | -26 | -5 |
| Investing Cash Flow | $-10 | $-8 | $-2 | $-26 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -141 | -106 | -71 | -113 | -86 |
| Common Stock Issued | 9,785 | 9,537 | 9,537 | 280 | 280 |
| Other Financing Activity | 278 | 278 | 278 | 5,026 | 4,398 |
| Financing Cash Flow | $9,922 | $9,709 | $9,744 | $5,193 | $4,592 |
| Beginning Cash Position | 429 | 429 | 429 | 70 | 70 |
| End Cash Position | 4,372 | 6,257 | 8,500 | 429 | 1,158 |
| Net Cash Flow | $3,944 | $5,829 | $8,071 | $359 | $1,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,968 | -3,873 | -1,671 | -4,809 | -3,499 |
| Capital Expenditure | -10 | -8 | -2 | -26 | -5 |
| Free Cash Flow | -5,978 | -3,881 | -1,673 | -4,835 | -3,504 |